| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.04 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |